Author: Mishra, Subodh Kumar; Shankar, Uma; Jain, Neha; Sikri, Kriti; Tyagi, Jaya Sivaswami; Sharma, Tarun Kumar; Mergny, Jean-Louis; Kumar, Amit
Title: Characterization of G-Quadruplex Motifs in espB, espK, and cyp51 Genes of Mycobacterium tuberculosis as Potential Drug Targets Document date: 2019_4_30
ID: qhkwn1on_3
Snippet: Currently, there are very few effective drugs available for the treatment of the M. tuberculosis infection, and the emergence of extremely drug-resistant strains and latent infections ring a global alarm for investigating novel conserved drug targets and drug regimens. 27, 28 Depending on nucleotide base composition, nucleic acids can adopt several distinct secondary structures such as duplex, triplex, hairpin, and quadruplex structures. 29 Among.....
Document: Currently, there are very few effective drugs available for the treatment of the M. tuberculosis infection, and the emergence of extremely drug-resistant strains and latent infections ring a global alarm for investigating novel conserved drug targets and drug regimens. 27, 28 Depending on nucleotide base composition, nucleic acids can adopt several distinct secondary structures such as duplex, triplex, hairpin, and quadruplex structures. 29 Among these secondary structures, the G-quadruplex structure has been represented as the most studied evolutionarily conserved drug target, and several small molecules have been developed that modulate (stabilize or destabilize) these G-quadruplex structures and have potential to be used as a promising drug target in the battle against human pathogens.
Search related documents:
Co phrase search for related documents- human pathogen and latent infection: 1, 2, 3, 4, 5
- human pathogen and nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- human pathogen and secondary structure: 1, 2
- human pathogen and small molecule: 1, 2, 3, 4, 5, 6
- human pathogen and tuberculosis infection: 1, 2
- latent infection and nucleic acid: 1, 2, 3
- latent infection and small molecule: 1, 2
- latent infection and tuberculosis infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- latent infection and tuberculosis infection treatment: 1, 2, 3
- nucleic acid and secondary structure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- nucleic acid and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- nucleic acid and tuberculosis infection: 1, 2, 3, 4
- secondary structure and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- small molecule and tuberculosis infection: 1
Co phrase search for related documents, hyperlinks ordered by date